These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3604256)

  • 1. The interaction between chronic oral slow-release theophylline and single-dose intravenous erythromycin.
    Pasic J; Jackson SH; Johnston A; Peverel-Cooper CA; Turner P; Downey K; Chaput de Saintonge DM
    Xenobiotica; 1987 Apr; 17(4):493-7. PubMed ID: 3604256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers.
    Jackson SH; Shah K; Debbas NM; Johnston A; Peverel-Cooper CA; Turner P
    Br J Clin Pharmacol; 1986 Apr; 21(4):389-92. PubMed ID: 3707813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of erythromycin with theophylline.
    Paulsen O; Höglund P; Nilsson LG; Bengtsson HI
    Eur J Clin Pharmacol; 1987; 32(5):493-8. PubMed ID: 3622597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A crossover study after oral and intravenous administration of theophylline in male volunteers (absolute bioavailability of Afonilum tablets).
    Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):339-45. PubMed ID: 6885204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.
    Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
    Arzneimittelforschung; 1984; 34(1):92-5. PubMed ID: 6538428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D
    Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of clinically important interaction between erythromycin and theophylline.
    Hildebrandt R; Gundert-Remy U; Möller H; Weber E
    Eur J Clin Pharmacol; 1984; 26(4):485-9. PubMed ID: 6734707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of theophylline on the renal clearance of erythromycin.
    Hildebrandt R; Möller H; Gundert-Remy U
    Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):601-4. PubMed ID: 3429062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects.
    Bialer M; Salame K; Raz I
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):662-7. PubMed ID: 4093206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The bioavailability of 4 sustained-release theophylline preparations from the Chilean market].
    Biagini L; Zamora P; Chávez H; Saavedra I
    Rev Med Chil; 1990 Nov; 118(11):1241-6. PubMed ID: 2152650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.